Astellas bought IVERIC for $40.00 per share in cash, for a total equity value of approximately $5.9 billion.
(Reporting by Baranjot Kaur in Bengaluru; Editing by Kim Coghill)
Astellas Pharma buys Iveric Bio for $5.9 billion
May 30, 2023 at 07:17 pm EDT
Share
(Reuters) - Japan's Astellas Pharma said on Monday it had fully acquired drugmaker IVERIC Bio Inc, through Berry Merger Sub, Inc, a wholly-owned subsidiary of Astellas US Holding, Inc.
Share
